Myelodysplastic syndromes trials in Netherlands

7 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  Where

  Amsterdam

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Takeda

  See details and how to joinNCT07422480 · EU 2025-523544-12-00
• Phase 3Taking people
  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  Where

  Amersfoort, Amsterdam, Arnhem, Breda, Delft, Den Bosch, Den Haag, Dordrecht, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden, Maastricht, Nieuwegein, Nijmegen, Rotterdam, Utrecht, Zwolle

  Age

  18 years to 75 years

  People

  650 worldwide

  Run by

  University of Ulm

  See details and how to joinNCT04628026 · EU 2023-507518-28-00
• Phase 2Taking people
  (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  Where

  Groningen

  Age

  18 years and over

  People

  140 worldwide

  Run by

  Cogent Biosciences, Inc.

  See details and how to joinNCT04996875 · EU 2024-511407-42-00
• Phase 3Taking people
  Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

  Where

  Amsterdam, Groningen

  Age

  18 years and over

  People

  48 worldwide

  Run by

  Institut de Recherches Internationales Servier

  See details and how to joinNCT06465953 · EU 2023-510155-37-00
• Phase 1/2Not yet taking people in Netherlands
  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  Where

  Amsterdam, Groningen, Maastricht, Nijmegen

  Age

  18 years and over

  People

  64 worldwide

  Run by

  Servier

  See details and how to joinNCT07719348 · EU 2025-525128-88-00
• Phase 3Taking people
  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Where

  Amsterdam

  Age

  18 years and over

  People

  665 worldwide

  Run by

  Celgene

  See details and how to joinNCT04064060
• Phase 1/2Taking people
  Study to Evaluate the Safety and Tolerability of EP0042

  Where

  Amsterdam, Rotterdam

  Age

  18 years and over

  People

  70 worldwide

  Run by

  Ellipses Pharma

  See details and how to joinNCT04581512 · EU 2024-514588-24-00